Temat: "CARDIOMYOPATHIES" - OpacWWW

Skocz do pozycji: 1.

Tytuł:: From gene to mechanics: a comprehensive insight into the mechanobiology of LMNA mutations in cardiomyopathy.
Autorzy:: Veltrop RJA; Department of Biochemistry, CARIM, Maastricht University, Maastricht, The Netherlands. .; Department of Cardiology, Division Heart and Lungs, University Medical Center Utrecht, Utrecht, the Netherlands. .; Regenerative Medicine Utrecht, University Medical Center Utrecht, Utrecht, The Netherlands. .; LMNAcardiac.org, LMNA Patient Organization, Soest, The Netherlands. .; Striated Muscle Laminopathy Consortium, ENMC, Baarn, The Netherlands. .
Kukk MM; Department of Biochemistry, CARIM, Maastricht University, Maastricht, The Netherlands.
Topouzidou K; Department of Biochemistry, CARIM, Maastricht University, Maastricht, The Netherlands.
Didden L; Department of Biochemistry, CARIM, Maastricht University, Maastricht, The Netherlands.
Muchir A; Centre de Recherche en Myologie, U974 SU-INSERM, 75013, Paris, France.
van Steenbeek FG; Department of Clinical Sciences of Companion Animals, Faculty of Veterinary Medicine, Utrecht University, Utrecht, The Netherlands.
Schurgers LJ; Department of Biochemistry, CARIM, Maastricht University, Maastricht, The Netherlands.
Harakalova M; Department of Cardiology, Division Heart and Lungs, University Medical Center Utrecht, Utrecht, the Netherlands.; Regenerative Medicine Utrecht, University Medical Center Utrecht, Utrecht, The Netherlands.; Pokaż więcej
Źródło:: Cell communication and signaling : CCS [Cell Commun Signal] 2024 Mar 27; Vol. 22 (1), pp. 197. Date of Electronic Publication: 2024 Mar 27.
Typ publikacji:: Journal Article; Review
MeSH Terms:: Cardiomyopathies*/genetics
Cardiomyopathies*/metabolism
Heart Failure*/genetics
Humans ; Mechanotransduction, Cellular ; Lamin Type A/genetics ; Lamin Type A/metabolism ; Mutation/genetics ; Biophysics

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 2.

Tytuł:: Guyton perspective in managing peripartum cardiomyopathy patient with pulmonary edema: a case report.
Autorzy:: Margaretha RE; Department of Anesthesiology and Intensive Care, Faculty of Medicine, Universitas Indonesia-Cipto Mangunkusumo General Hospital, Jakarta, Indonesia. .; Semen Padang Hospital, Jl. Raya By Pass Km. 7, Kecamatan Pauh, West Sumatera, Indonesia. .
George YWH; Department of Anesthesiology and Intensive Care, Faculty of Medicine, Universitas Indonesia-Cipto Mangunkusumo General Hospital, Jakarta, Indonesia.
Hidayat J; Department of Anesthesiology and Intensive Care, Faculty of Medicine, Universitas Indonesia-Cipto Mangunkusumo General Hospital, Jakarta, Indonesia.; Pokaż więcej
Źródło:: Journal of medical case reports [J Med Case Rep] 2024 Feb 12; Vol. 18 (1), pp. 87. Date of Electronic Publication: 2024 Feb 12.
Typ publikacji:: Case Reports; Journal Article
MeSH Terms:: Pulmonary Edema*/etiology
Pulmonary Edema*/therapy
Pre-Eclampsia*
Cardiomyopathies*/complications
Cardiomyopathies*/therapy
Cardiomyopathies*/diagnosis
Heart Failure*/complications
Heart Failure*/therapy
Puerperal Disorders*/drug therapy
Pregnancy Complications, Cardiovascular*/diagnostic imaging
Pregnancy Complications, Cardiovascular*/therapy
Pregnancy ; Female ; Humans ; Adult ; Furosemide/therapeutic use ; Peripartum Period

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 3.

Tytuł:: Characterizing diabetic cardiomyopathy: baseline results from the ARISE-HF trial.
Autorzy:: Januzzi JL; Heart Failure Trials, Baim Institute for Clinical Research, Boston, MA, USA. .; Cardiology Division, Massachusetts General Hospital, Harvard Medical School, 55 Fruit Street, 02114, Boston, MA, USA. .
Del Prato S; Interdisciplinary Research Center 'Health Science', Sant'Anna School of Advanced Studies, Pisa, Italy.
Rosenstock J; Velocity Clinical Research at Medical City and University of Texas, Southwestern Medical Center, Dallas, TX, USA.
Butler J; Baylor Scott and White Research Institute, , Dallas, TX, USA.; University of Mississippi, Jackson, MS, USA.
Ezekowitz J; Canadian VIGOUR Centre, University of Alberta, Edmonton, AB, Canada.
Ibrahim NE; Cardiology Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Lam CSP; National Heart Centre Singapore and Duke-National University of Singapore, Singapore, Singapore.
Marwick T; Baker Heart and Diabetes Institute, Melbourne, Australia.; Menzies Institute for Medical Research, Hobart, Australia.
Wilson Tang WH; Department of Cardiovascular Medicine, Heart Vascular and Thoracic Institute, Cleveland Clinic, Cleveland, OH, USA.
Liu Y; Cardiology Division, Massachusetts General Hospital, Harvard Medical School, 55 Fruit Street, 02114, Boston, MA, USA.
Mohebi R; Cardiology Division, Massachusetts General Hospital, Harvard Medical School, 55 Fruit Street, 02114, Boston, MA, USA.
Urbinati A; Applied Therapeutics Inc, New York, NY, USA.
Zannad F; Université de Lorraine, CIC Inserm and CHRU Nancy, Lorraine, France.
Perfetti R; Applied Therapeutics Inc, New York, NY, USA.; Pokaż więcej
Źródło:: Cardiovascular diabetology [Cardiovasc Diabetol] 2024 Feb 01; Vol. 23 (1), pp. 49. Date of Electronic Publication: 2024 Feb 01.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Diabetic Cardiomyopathies*/diagnostic imaging
Diabetic Cardiomyopathies*/etiology
Diabetes Mellitus, Type 2*/complications
Diabetes Mellitus, Type 2*/diagnosis
Diabetes Mellitus, Type 2*/drug therapy
Heart Failure*/diagnosis
Humans ; Female ; Aged ; Male ; Stroke Volume ; Hypertrophy, Left Ventricular ; Ventricular Function, Left

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 4.

Tytuł:: Dilated cardiomyopathy due to hypocalcaemia: a case report.
Autorzy:: Rupasinghe N; Ministry of Health, Colombo, Sri Lanka.
Ranasinghe P; Department of Pharmacology, Faculty of Medicine, University of Colombo, Colombo, Sri Lanka.
Wanninayake L; Department of Pharmacology, Faculty of Medicine, University of Colombo, Colombo, Sri Lanka. .; Pokaż więcej
Źródło:: Journal of medical case reports [J Med Case Rep] 2024 Apr 11; Vol. 18 (1), pp. 204. Date of Electronic Publication: 2024 Apr 11.
Typ publikacji:: Case Reports; Journal Article
MeSH Terms:: Hypocalcemia*/complications
Hypocalcemia*/drug therapy
Cardiomyopathy, Dilated*/complications
Cardiomyopathy, Dilated*/diagnosis
Cardiomyopathies*/complications
Heart Failure*/complications
Female ; Humans ; Middle Aged ; Calcium/therapeutic use

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 5.

Tytuł:: Progress in the treatment of diabetic cardiomyopathy, a systematic review.
Autorzy:: Shou Y; Department of Clinical Medicine, Affiliated Hospital of Hangzhou Normal University, Hangzhou Normal University, Hangzhou, China.
Li X; Department of Clinical Medicine, Affiliated Hospital of Hangzhou Normal University, Hangzhou Normal University, Hangzhou, China.
Fang Q; Department of Clinical Medicine, Affiliated Hospital of Hangzhou Normal University, Hangzhou Normal University, Hangzhou, China.
Xie A; Department of Clinical Medicine, Affiliated Hospital of Hangzhou Normal University, Hangzhou Normal University, Hangzhou, China.
Zhang Y; Department of Immunology, Affiliated Hospital of Hangzhou Normal University, Hangzhou, China.
Fu X; Department of Cardiology, Affiliated Hospital of Hangzhou Normal University, Hangzhou, China.
Wang M; Department of Cardiology, Affiliated Hospital of Hangzhou Normal University, Hangzhou, China.
Gong W; Department of Clinical Medicine, Affiliated Hospital of Hangzhou Normal University, Hangzhou Normal University, Hangzhou, China.; Department of Cardiology, Affiliated Hospital of Hangzhou Normal University, Hangzhou, China.
Zhang X; Department of Clinical Medicine, Affiliated Hospital of Hangzhou Normal University, Hangzhou Normal University, Hangzhou, China.; Department of Cardiology, Affiliated Hospital of Hangzhou Normal University, Hangzhou, China.
Yang D; Department of Clinical Medicine, Affiliated Hospital of Hangzhou Normal University, Hangzhou Normal University, Hangzhou, China.; Department of Cardiology, Affiliated Hospital of Hangzhou Normal University, Hangzhou, China.; Pokaż więcej
Źródło:: Pharmacology research & perspectives [Pharmacol Res Perspect] 2024 Apr; Vol. 12 (2), pp. e1177.
Typ publikacji:: Systematic Review; Journal Article; Review
MeSH Terms:: Diabetic Cardiomyopathies*/drug therapy
Heart Failure*
Coronary Artery Disease*
Myocardial Infarction*
Cardiovascular Agents*
Diabetes Mellitus*
Humans

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 6.

Tytuł:: Prognostic value of measurement of myocardial extracellular volume using dual-energy CT in heart failure with preserved ejection fraction.
Autorzy:: Jiang Y; Department of General Practice, The Second Affiliated Hospital of Nantong University, Shengli Road No.666, Nantong, 226001, China.
Ye J; Department of General Practice, The Second Affiliated Hospital of Nantong University, Shengli Road No.666, Nantong, 226001, China.
Yang Y; Department of General Practice, The Second Affiliated Hospital of Nantong University, Shengli Road No.666, Nantong, 226001, China.
Zhang Y; Department of General Practice, The Second Affiliated Hospital of Nantong University, Shengli Road No.666, Nantong, 226001, China.
Yan X; Department of General Practice, The Second Affiliated Hospital of Nantong University, Shengli Road No.666, Nantong, 226001, China.
Qiang W; Department of General Practice, The Second Affiliated Hospital of Nantong University, Shengli Road No.666, Nantong, 226001, China.
Chen H; Department of General Practice, The Second Affiliated Hospital of Nantong University, Shengli Road No.666, Nantong, 226001, China.
Xu S; Department of General Practice, The Second Affiliated Hospital of Nantong University, Shengli Road No.666, Nantong, 226001, China.
Zhou L; Department of Cardiology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, 210029, China. .
Qi R; Department of Radiology, The Second Affiliated Hospital of Nantong University, Shengli Road No.666, Nantong, 226001, China. .
Zhang Q; Department of General Practice, The Second Affiliated Hospital of Nantong University, Shengli Road No.666, Nantong, 226001, China. .; Pokaż więcej
Źródło:: Scientific reports [Sci Rep] 2024 Mar 29; Vol. 14 (1), pp. 7504. Date of Electronic Publication: 2024 Mar 29.
Typ publikacji:: Journal Article
MeSH Terms:: Heart Failure*/diagnostic imaging
Cardiomyopathies*
Humans ; Prognosis ; Stroke Volume ; Retrospective Studies ; Magnetic Resonance Imaging, Cine ; Fibrosis ; Tomography, X-Ray Computed ; Ventricular Function, Left ; Predictive Value of Tests

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 7.

Tytuł:: Anserine, a Histidine-Containing Dipeptide, Suppresses Pressure Overload-Induced Systolic Dysfunction by Inhibiting Histone Acetyltransferase Activity of p300 in Mice.
Autorzy:: Sunagawa Y; Division of Molecular Medicine, School of Pharmaceutical Sciences, University of Shizuoka, Shizuoka 422-8526, Japan.; Division of Translational Research, National Hospital Organization Kyoto Medical Center, Kyoto 612-8555, Japan.; Shizuoka General Hospital, Shizuoka 420-8527, Japan.
Tsukabe R; Division of Molecular Medicine, School of Pharmaceutical Sciences, University of Shizuoka, Shizuoka 422-8526, Japan.
Irokawa Y; Division of Molecular Medicine, School of Pharmaceutical Sciences, University of Shizuoka, Shizuoka 422-8526, Japan.
Funamoto M; Division of Molecular Medicine, School of Pharmaceutical Sciences, University of Shizuoka, Shizuoka 422-8526, Japan.; Division of Translational Research, National Hospital Organization Kyoto Medical Center, Kyoto 612-8555, Japan.; Department of Pharmacology, Institute of Biomedical Sciences, Tokushima University Graduate School, Tokushima 770-8503, Japan.
Suzuki Y; Division of Molecular Medicine, School of Pharmaceutical Sciences, University of Shizuoka, Shizuoka 422-8526, Japan.
Yamada M; Division of Molecular Medicine, School of Pharmaceutical Sciences, University of Shizuoka, Shizuoka 422-8526, Japan.
Shimizu S; Division of Molecular Medicine, School of Pharmaceutical Sciences, University of Shizuoka, Shizuoka 422-8526, Japan.; Division of Translational Research, National Hospital Organization Kyoto Medical Center, Kyoto 612-8555, Japan.
Katanasaka Y; Division of Molecular Medicine, School of Pharmaceutical Sciences, University of Shizuoka, Shizuoka 422-8526, Japan.; Division of Translational Research, National Hospital Organization Kyoto Medical Center, Kyoto 612-8555, Japan.; Shizuoka General Hospital, Shizuoka 420-8527, Japan.
Hamabe-Horiike T; Division of Molecular Medicine, School of Pharmaceutical Sciences, University of Shizuoka, Shizuoka 422-8526, Japan.; Division of Translational Research, National Hospital Organization Kyoto Medical Center, Kyoto 612-8555, Japan.; Shizuoka General Hospital, Shizuoka 420-8527, Japan.
Kawase Y; Division of Molecular Medicine, School of Pharmaceutical Sciences, University of Shizuoka, Shizuoka 422-8526, Japan.
Naruta R; Division of Molecular Medicine, School of Pharmaceutical Sciences, University of Shizuoka, Shizuoka 422-8526, Japan.
Shimizu K; Division of Molecular Medicine, School of Pharmaceutical Sciences, University of Shizuoka, Shizuoka 422-8526, Japan.; Division of Translational Research, National Hospital Organization Kyoto Medical Center, Kyoto 612-8555, Japan.
Mori K; Shizuoka General Hospital, Shizuoka 420-8527, Japan.; Graduate School of Public Health, Shizuoka Graduate University of Public Health, Shizuoka 420-0881, Japan.; Department of Molecular and Clinical Pharmacology, School of Pharmaceutical Sciences, University of Shizuoka, Shizuoka 422-8526, Japan.
Hosomi R; Laboratory of Food and Nutritional Sciences, Faculty of Chemistry, Materials and Bioengineering, Kansai University, Osaka 564-8680, Japan.
Komiyama M; Division of Translational Research, National Hospital Organization Kyoto Medical Center, Kyoto 612-8555, Japan.
Hasegawa K; Division of Molecular Medicine, School of Pharmaceutical Sciences, University of Shizuoka, Shizuoka 422-8526, Japan.; Division of Translational Research, National Hospital Organization Kyoto Medical Center, Kyoto 612-8555, Japan.
Morimoto T; Division of Molecular Medicine, School of Pharmaceutical Sciences, University of Shizuoka, Shizuoka 422-8526, Japan.; Division of Translational Research, National Hospital Organization Kyoto Medical Center, Kyoto 612-8555, Japan.; Shizuoka General Hospital, Shizuoka 420-8527, Japan.; Pokaż więcej
Źródło:: International journal of molecular sciences [Int J Mol Sci] 2024 Feb 16; Vol. 25 (4). Date of Electronic Publication: 2024 Feb 16.
Typ publikacji:: Journal Article
MeSH Terms:: Anserine*/pharmacology
Cardiomyopathies*/metabolism
Heart Failure*/metabolism
Myocytes, Cardiac*/drug effects
Myocytes, Cardiac*/metabolism
p300-CBP Transcription Factors*/antagonists & inhibitors
Animals ; Humans ; Male ; Mice ; Acetylation ; Cardiomegaly/genetics ; Enzyme Inhibitors/pharmacology ; Histones/metabolism ; Mice, Inbred C57BL ; Phenylephrine/pharmacology

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 8.

Tytuł:: Treatment with recombinant Sirt1 rewires the cardiac lipidome and rescues diabetes-related metabolic cardiomyopathy.
Autorzy:: Costantino S; Center for Translational and Experimental Cardiology (CTEC), Department of Cardiology, Zurich University Hospital and University of Zurich, Wagistrasse 12, 8952, Schlieren, Switzerland.; Department of Cardiology, Zurich University Hospital, Zurich, Switzerland.
Mengozzi A; Center for Translational and Experimental Cardiology (CTEC), Department of Cardiology, Zurich University Hospital and University of Zurich, Wagistrasse 12, 8952, Schlieren, Switzerland.; Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.; Health Science Interdisciplinary Center, Sant'Anna School of Advanced Studies, Pisa, Italy.
Velagapudi S; Center for Molecular Cardiology, University of Zurich, Zurich, Switzerland.
Mohammed SA; Center for Translational and Experimental Cardiology (CTEC), Department of Cardiology, Zurich University Hospital and University of Zurich, Wagistrasse 12, 8952, Schlieren, Switzerland.
Gorica E; Center for Translational and Experimental Cardiology (CTEC), Department of Cardiology, Zurich University Hospital and University of Zurich, Wagistrasse 12, 8952, Schlieren, Switzerland.
Akhmedov A; Center for Molecular Cardiology, University of Zurich, Zurich, Switzerland.
Mongelli A; Center for Translational and Experimental Cardiology (CTEC), Department of Cardiology, Zurich University Hospital and University of Zurich, Wagistrasse 12, 8952, Schlieren, Switzerland.
Pugliese NR; Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
Masi S; Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
Virdis A; Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
Hülsmeier A; Institute for Clinical Chemistry, University Hospital and University of Zürich, Zurich, Switzerland.
Matter CM; Center for Translational and Experimental Cardiology (CTEC), Department of Cardiology, Zurich University Hospital and University of Zurich, Wagistrasse 12, 8952, Schlieren, Switzerland.; Department of Cardiology, Zurich University Hospital, Zurich, Switzerland.
Hornemann T; Institute for Clinical Chemistry, University Hospital and University of Zürich, Zurich, Switzerland.
Melina G; Department of Clinical and Molecular Medicine, Sapienza University of Rome, Rome, Italy.
Ruschitzka F; Center for Translational and Experimental Cardiology (CTEC), Department of Cardiology, Zurich University Hospital and University of Zurich, Wagistrasse 12, 8952, Schlieren, Switzerland.; Department of Cardiology, Zurich University Hospital, Zurich, Switzerland.
Luscher TF; Center for Molecular Cardiology, University of Zurich, Zurich, Switzerland.; Royal Brompton and Harefield Hospitals and Imperial College, London, UK.
Paneni F; Center for Translational and Experimental Cardiology (CTEC), Department of Cardiology, Zurich University Hospital and University of Zurich, Wagistrasse 12, 8952, Schlieren, Switzerland. .; Department of Cardiology, Zurich University Hospital, Zurich, Switzerland. .; Pokaż więcej
Źródło:: Cardiovascular diabetology [Cardiovasc Diabetol] 2023 Nov 13; Vol. 22 (1), pp. 312. Date of Electronic Publication: 2023 Nov 13.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Diabetes Mellitus*/metabolism
Diabetic Cardiomyopathies*/genetics
Diabetic Cardiomyopathies*/prevention & control
Heart Failure*/metabolism
Animals ; Humans ; Mice ; Inflammation/metabolism ; Lipidomics ; Lipids ; Myocytes, Cardiac/metabolism ; PPAR gamma/metabolism ; Sirtuin 1/genetics ; Sirtuin 1/metabolism ; Stroke Volume ; Triglycerides/metabolism ; Ventricular Function, Left

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 9.

Tytuł:: Biomarkers in Peripartum Cardiomyopathy-What We Know and What Is Still to Be Found.
Autorzy:: Kryczka KE; Department of Coronary and Structural Heart Diseases, National Institute of Cardiology, 04-628 Warsaw, Poland.
Demkow M; Department of Coronary and Structural Heart Diseases, National Institute of Cardiology, 04-628 Warsaw, Poland.
Dzielińska Z; Department of Coronary and Structural Heart Diseases, National Institute of Cardiology, 04-628 Warsaw, Poland.; Pokaż więcej
Źródło:: Biomolecules [Biomolecules] 2024 Jan 12; Vol. 14 (1). Date of Electronic Publication: 2024 Jan 12.
Typ publikacji:: Journal Article; Review
MeSH Terms:: Cardiomyopathies*/diagnosis
MicroRNAs*/genetics
Heart Failure*/diagnosis
Pregnancy ; Humans ; Female ; Bromocriptine/therapeutic use ; Endothelial Cells ; Microcirculation ; Peripartum Period ; Placenta Growth Factor ; Biomarkers

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 10.

Tytuł:: Effects of SGLT2 inhibitors on cardiac function and health status in chronic heart failure: a systematic review and meta-analysis.
Autorzy:: Chen J; Department of Endocrinology and Metabolism, the Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan, China.; Department of Endocrinology, The Third Hospital of Mianyang, Sichuan Mental Health Center, Mianyang, Sichuan, China.; Sichuan Clinical Research Center for Nephropathy, Luzhou, Sichuan, China.; Metabolic Vascular Disease Key Laboratory of Sichuan Province, Luzhou, China.
Jiang C; Department of Endocrinology and Metabolism, the Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan, China.; Sichuan Clinical Research Center for Nephropathy, Luzhou, Sichuan, China.; Metabolic Vascular Disease Key Laboratory of Sichuan Province, Luzhou, China.; State Key Laboratory of Quality Research in Chinese Medicine, Macau University of Science and Technology, Macao, China.; Faculty of Chinese Medicine, Macau University of Science and Technology, Macao, China.
Guo M; Department of Endocrinology and Metabolism, the Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan, China.; Sichuan Clinical Research Center for Nephropathy, Luzhou, Sichuan, China.; Metabolic Vascular Disease Key Laboratory of Sichuan Province, Luzhou, China.
Zeng Y; Department of Endocrinology and Metabolism, the Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan, China.; Sichuan Clinical Research Center for Nephropathy, Luzhou, Sichuan, China.; Metabolic Vascular Disease Key Laboratory of Sichuan Province, Luzhou, China.
Jiang Z; Department of Endocrinology and Metabolism, the Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan, China.; Sichuan Clinical Research Center for Nephropathy, Luzhou, Sichuan, China.; Metabolic Vascular Disease Key Laboratory of Sichuan Province, Luzhou, China.
Zhang D; Department of Endocrinology, The Third Hospital of Mianyang, Sichuan Mental Health Center, Mianyang, Sichuan, China.
Tu M; Department of Endocrinology and Metabolism, the Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan, China.; Sichuan Clinical Research Center for Nephropathy, Luzhou, Sichuan, China.; Metabolic Vascular Disease Key Laboratory of Sichuan Province, Luzhou, China.
Tan X; Department of Endocrinology and Metabolism, the Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan, China.; Sichuan Clinical Research Center for Nephropathy, Luzhou, Sichuan, China.; Metabolic Vascular Disease Key Laboratory of Sichuan Province, Luzhou, China.
Yan P; Department of Endocrinology and Metabolism, the Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan, China.; Sichuan Clinical Research Center for Nephropathy, Luzhou, Sichuan, China.; Metabolic Vascular Disease Key Laboratory of Sichuan Province, Luzhou, China.
Xu X; Department of Endocrinology, The Third Hospital of Mianyang, Sichuan Mental Health Center, Mianyang, Sichuan, China. .
Long Y; Department of Endocrinology and Metabolism, the Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan, China. .; Sichuan Clinical Research Center for Nephropathy, Luzhou, Sichuan, China. .; Metabolic Vascular Disease Key Laboratory of Sichuan Province, Luzhou, China. .
Xu Y; Department of Endocrinology and Metabolism, the Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan, China. .; Sichuan Clinical Research Center for Nephropathy, Luzhou, Sichuan, China. .; Metabolic Vascular Disease Key Laboratory of Sichuan Province, Luzhou, China. .; Pokaż więcej
Źródło:: Cardiovascular diabetology [Cardiovasc Diabetol] 2024 Jan 03; Vol. 23 (1), pp. 2. Date of Electronic Publication: 2024 Jan 03.
Typ publikacji:: Meta-Analysis; Systematic Review; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Sodium-Glucose Transporter 2 Inhibitors*/adverse effects
Heart Failure*/diagnosis
Heart Failure*/drug therapy
Diabetes Mellitus, Type 2*/diagnosis
Diabetes Mellitus, Type 2*/drug therapy
Cardiomyopathies*/drug therapy
Humans ; Natriuretic Peptide, Brain ; Health Status ; Chronic Disease ; Randomized Controlled Trials as Topic

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 11.

Tytuł:: Risk stratification in patients with structurally normal hearts: Does fibrosis type matter?
Autorzy:: Gil KE; The Ohio State University Division of Cardiovascular Medicine, Columbus, OH, United States of America.
Mikrut K; Advocate Heart Institute, Advocate Lutheran General Hospital, Chicago, IL, United States of America.
Mazur J; University of Cincinnati College of Medicine, Cincinnati, OH, United States of America.
Black AL; The Ohio State University College of Medicine, Columbus, OH, United States of America.
Truong VT; Department of Internal Medicine, Nazareth Hospital, Philadelphia, PA, United States of America.
Smart S; Dorothy M. Davis Heart and Lung Research Institute, The Ohio State University, Columbus, OH, United States of America.
Zareba KM; The Ohio State University Division of Cardiovascular Medicine, Columbus, OH, United States of America.; Dorothy M. Davis Heart and Lung Research Institute, The Ohio State University, Columbus, OH, United States of America.; Pokaż więcej
Źródło:: PloS one [PLoS One] 2023 Dec 20; Vol. 18 (12), pp. e0295519. Date of Electronic Publication: 2023 Dec 20 (Print Publication: 2023).
Typ publikacji:: Journal Article
MeSH Terms:: Cardiomyopathies*/pathology
Heart Failure*
Male ; Humans ; Adult ; Middle Aged ; Female ; Myocardium/pathology ; Contrast Media ; Stroke Volume ; Magnetic Resonance Imaging, Cine ; Gadolinium ; Fibrosis ; Risk Assessment ; Predictive Value of Tests

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 12.

Tytuł:: Toxic Cardiomyopathy in a Young Patient Treated for Her2-Positive Early Breast Cancer: Case Report and Literature Review.
Autorzy:: Hadžibeganović A; Clinic for Oncology and Radiotherapy, University Clinical Center Tuzla. .
Koprić D; Clinic for Oncology and Radiotherapy, University Clinical Center Tuzla.; Pokaż więcej
Źródło:: Acta medica academica [Acta Med Acad] 2023 Dec; Vol. 52 (3), pp. 225-230.
Typ publikacji:: Case Reports; Review; Journal Article
MeSH Terms:: Breast Neoplasms*/drug therapy
Biosimilar Pharmaceuticals*/therapeutic use
Heart Failure*/etiology
Heart Failure*/drug therapy
Cardiomyopathies*/drug therapy
Female ; Humans ; Adult ; Receptor, ErbB-2/therapeutic use ; Antibodies, Monoclonal, Humanized/therapeutic use ; Trastuzumab/adverse effects ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Neoadjuvant Therapy

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 13.

Tytuł:: The Role of Genetics in the Management of Heart Failure Patients.
Autorzy:: Palmieri G; School of Cardiology, Department of Medical and Surgical Sciences, University of Foggia, 70122 Foggia, Italy.
D'Ambrosio MF; Medical Genetics, Department of Clinical and Experimental Medicine, University of Foggia, 70122 Foggia, Italy.
Correale M; School of Cardiology, Department of Medical and Surgical Sciences, University of Foggia, 70122 Foggia, Italy.
Brunetti ND; School of Cardiology, Department of Medical and Surgical Sciences, University of Foggia, 70122 Foggia, Italy.
Santacroce R; Medical Genetics, Department of Clinical and Experimental Medicine, University of Foggia, 70122 Foggia, Italy.
Iacoviello M; University Cardiology Unit, Polyclinic Hospital of Bari, 70124 Bari, Italy.
Margaglione M; Medical Genetics, Department of Clinical and Experimental Medicine, University of Foggia, 70122 Foggia, Italy.; Pokaż więcej
Źródło:: International journal of molecular sciences [Int J Mol Sci] 2023 Oct 16; Vol. 24 (20). Date of Electronic Publication: 2023 Oct 16.
Typ publikacji:: Journal Article; Review
MeSH Terms:: Heart Failure*/genetics
Heart Failure*/therapy
Heart Failure*/diagnosis
Cardiomyopathies*/metabolism
Cardiovascular Diseases*/complications
Cardiologists*
Humans

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 14.

Tytuł:: Transthyretin Amyloid Cardiomyopathy Risk Evaluation in a Cohort of Patients With Heart Failure.
Autorzy:: Suh AA; Pharmacy Department, Kaiser Permanente Colorado, Aurora, CO, USA.
Shaw PB; Pharmacy Department, Kaiser Permanente Colorado, Aurora, CO, USA.
Jeong MY; Cardiology Department, Colorado Permanente Medical Group, Aurora, CO, USA.; Cardiology Department, Colorado Permanente Medical Group, Saint Joseph Hospital, Denver, CO, USA.
Olson KL; Pharmacy Department, Kaiser Permanente Colorado, Aurora, CO, USA.
Delate T; Pharmacy Outcomes Research Group, Kaiser Permanente National Pharmacy, Aurora, CO, USA.; Pokaż więcej
Źródło:: The Permanente journal [Perm J] 2023 Jun 15; Vol. 27 (2), pp. 51-60. Date of Electronic Publication: 2023 Mar 27.
Typ publikacji:: Observational Study; Journal Article
MeSH Terms:: Cardiomyopathies*/complications
Amyloid Neuropathies, Familial*/complications
Amyloid Neuropathies, Familial*/diagnosis
Heart Failure*/complications
Heart Failure*/epidemiology
Atrial Fibrillation*
Humans ; Prealbumin

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 15.

Tytuł:: The Role of Cardiac Fibrosis in Diabetic Cardiomyopathy: From Pathophysiology to Clinical Diagnostic Tools.
Autorzy:: Pan KL; Division of Cardiology, Department of Internal Medicine, Chang Gung Memorial Hospital, Chiayi Branch, Chiayi City 613, Taiwan.; College of Medicine, Chang Gung University, Taoyuan City 333, Taiwan.; Heart Failure Center, Chang Gung Memorial Hospital, Chiayi Branch, Chiayi City 613, Taiwan.
Hsu YC; Department of Nephrology, Kidney and Diabetic Complications Research Team (KDCRT), Chang Gung Memorial Hospital, Chiayi Branch, Chiayi City 613, Taiwan.
Chang ST; Division of Cardiology, Department of Internal Medicine, Chang Gung Memorial Hospital, Chiayi Branch, Chiayi City 613, Taiwan.; College of Medicine, Chang Gung University, Taoyuan City 333, Taiwan.
Chung CM; Division of Cardiology, Department of Internal Medicine, Chang Gung Memorial Hospital, Chiayi Branch, Chiayi City 613, Taiwan.; College of Medicine, Chang Gung University, Taoyuan City 333, Taiwan.
Lin CL; College of Medicine, Chang Gung University, Taoyuan City 333, Taiwan.; Department of Nephrology, Kidney and Diabetic Complications Research Team (KDCRT), Chang Gung Memorial Hospital, Chiayi Branch, Chiayi City 613, Taiwan.; Kidney Research Center, Chang Gung Memorial Hospital, Taipei 105, Taiwan.; Center for Shockwave Medicine and Tissue Engineering, Department of Medical Research, Chang Gung Memorial Hospital, Kaohsiung City 833, Taiwan.; Pokaż więcej
Źródło:: International journal of molecular sciences [Int J Mol Sci] 2023 May 11; Vol. 24 (10). Date of Electronic Publication: 2023 May 11.
Typ publikacji:: Journal Article; Review
MeSH Terms:: Diabetic Cardiomyopathies*/diagnosis
Diabetic Cardiomyopathies*/etiology
Diabetic Cardiomyopathies*/metabolism
Heart Failure*/metabolism
Hyperglycemia*/metabolism
Diabetes Mellitus*
Humans ; Stroke Volume ; Fibrosis

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 16.

Tytuł:: Atrial Cardiomyopathy in Valvular Heart Disease: From Molecular Biology to Clinical Perspectives.
Autorzy:: Molnár AÁ; Heart and Vascular Center, Semmelweis University, 1122 Budapest, Hungary.
Sánta A; Heart and Vascular Center, Semmelweis University, 1122 Budapest, Hungary.
Pásztor DT; Heart and Vascular Center, Semmelweis University, 1122 Budapest, Hungary.
Merkely B; Heart and Vascular Center, Semmelweis University, 1122 Budapest, Hungary.; Pokaż więcej
Źródło:: Cells [Cells] 2023 Jul 06; Vol. 12 (13). Date of Electronic Publication: 2023 Jul 06.
Typ publikacji:: Journal Article; Review; Research Support, Non-U.S. Gov't
MeSH Terms:: Atrial Fibrillation*
Heart Valve Diseases*/complications
Heart Valve Diseases*/drug therapy
Cardiomyopathies*/complications
Heart Failure*/complications
Humans ; Fibrosis ; Molecular Biology

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 17.

Tytuł:: A case of infantile Barth syndrome with severe heart failure: Importance of splicing variants in the TAZ gene.
Autorzy:: Takeda A; Department of Pediatrics, Faculty of Medicine, Hokkaido University, Sapporo, Japan.
Ueki M; Department of Pediatrics, Faculty of Medicine, Hokkaido University, Sapporo, Japan.
Abe J; MRC Mitochondrial Biology Unit, University of Cambridge, Cambridge, UK.
Maeta K; KNC Department of Nucleic Acid Drug Discovery, Faculty of Rehabilitation, Kobe Gakuin University, Kobe, Japan.; Research Center for Locomotion Biology, Kobe Gakuin University, Kobe, Japan.
Horiguchi T; KNC Department of Nucleic Acid Drug Discovery, Faculty of Rehabilitation, Kobe Gakuin University, Kobe, Japan.; Research Center for Locomotion Biology, Kobe Gakuin University, Kobe, Japan.
Yamazawa H; Department of Pediatrics, Faculty of Medicine, Hokkaido University, Sapporo, Japan.
Izumi G; Department of Pediatrics, Faculty of Medicine, Hokkaido University, Sapporo, Japan.
Chida-Nagai A; Department of Pediatrics, Faculty of Medicine, Hokkaido University, Sapporo, Japan.
Sasaki D; Department of Pediatrics, Faculty of Medicine, Hokkaido University, Sapporo, Japan.
Tsujioka T; Department of Pediatrics, Faculty of Medicine, Hokkaido University, Sapporo, Japan.
Sato I; Department of Pediatrics, Faculty of Medicine, Hokkaido University, Sapporo, Japan.
Shiraishi M; Department of Pediatrics, Faculty of Medicine, Hokkaido University, Sapporo, Japan.
Matsuo M; KNC Department of Nucleic Acid Drug Discovery, Faculty of Rehabilitation, Kobe Gakuin University, Kobe, Japan.; Research Center for Locomotion Biology, Kobe Gakuin University, Kobe, Japan.; Faculty of Health Sciences, Kobe Tokiwa University, Kobe, Japan.; Pokaż więcej
Źródło:: Molecular genetics & genomic medicine [Mol Genet Genomic Med] 2023 Jul; Vol. 11 (7), pp. e2190. Date of Electronic Publication: 2023 Apr 25.
Typ publikacji:: Case Reports; Journal Article
MeSH Terms:: Barth Syndrome*/genetics
Barth Syndrome*/pathology
Cardiomyopathies*/genetics
Heart Defects, Congenital*/genetics
Heart Failure*/genetics
Humans ; Transcription Factors/genetics

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 18.

Tytuł:: Treatment of Cardiac Fibrosis with Extracellular Vesicles: What Is Missing for Clinical Translation?
Autorzy:: Neuber S; Department of Cardiothoracic and Vascular Surgery, Deutsches Herzzentrum der Charité (DHZC), 13353 Berlin, Germany.; Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, 13353 Berlin, Germany.; BIH Center for Regenerative Therapies (BCRT), Berlin Institute of Health at Charité-Universitätsmedizin Berlin, 13353 Berlin, Germany.; German Centre for Cardiovascular Research (DZHK), Partner Site Berlin, 13353 Berlin, Germany.
Ermer MR; Department of Cardiothoracic and Vascular Surgery, Deutsches Herzzentrum der Charité (DHZC), 13353 Berlin, Germany.; Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, 13353 Berlin, Germany.; BIH Center for Regenerative Therapies (BCRT), Berlin Institute of Health at Charité-Universitätsmedizin Berlin, 13353 Berlin, Germany.
Emmert MY; Department of Cardiothoracic and Vascular Surgery, Deutsches Herzzentrum der Charité (DHZC), 13353 Berlin, Germany.; Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, 13353 Berlin, Germany.; BIH Center for Regenerative Therapies (BCRT), Berlin Institute of Health at Charité-Universitätsmedizin Berlin, 13353 Berlin, Germany.; German Centre for Cardiovascular Research (DZHK), Partner Site Berlin, 13353 Berlin, Germany.; Institute for Regenerative Medicine, University of Zurich, 8044 Zurich, Switzerland.
Nazari-Shafti TZ; Department of Cardiothoracic and Vascular Surgery, Deutsches Herzzentrum der Charité (DHZC), 13353 Berlin, Germany.; Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, 13353 Berlin, Germany.; BIH Center for Regenerative Therapies (BCRT), Berlin Institute of Health at Charité-Universitätsmedizin Berlin, 13353 Berlin, Germany.; German Centre for Cardiovascular Research (DZHK), Partner Site Berlin, 13353 Berlin, Germany.; Pokaż więcej
Źródło:: International journal of molecular sciences [Int J Mol Sci] 2023 Jun 22; Vol. 24 (13). Date of Electronic Publication: 2023 Jun 22.
Typ publikacji:: Journal Article; Review
MeSH Terms:: Cardiomyopathies*/pathology
Heart Failure*/pathology
Extracellular Vesicles*/pathology
Humans ; Heart ; Fibrosis

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 19.

Tytuł:: Myocardial Inflammation as a Manifestation of Genetic Cardiomyopathies: From Bedside to the Bench.
Autorzy:: Peretto G; Department of Cardiac Electrophysiology and Arrhythmology, IRCCS San Raffaele Scientific Institute, 20132 Milan, Italy.; School of Medicine, Vita-Salute San Raffaele University, 20132 Milan, Italy.
Sommariva E; Unit of Vascular Biology and Regenerative Medicine, Centro Cardiologico Monzino IRCCS, 20139 Milan, Italy.
Di Resta C; School of Medicine, Vita-Salute San Raffaele University, 20132 Milan, Italy.; Genomic Unit for the Diagnosis of Human Pathologies, IRCCS San Raffaele Scientific Institute, 20132 Milan, Italy.
Rabino M; Unit of Vascular Biology and Regenerative Medicine, Centro Cardiologico Monzino IRCCS, 20139 Milan, Italy.
Villatore A; Department of Cardiac Electrophysiology and Arrhythmology, IRCCS San Raffaele Scientific Institute, 20132 Milan, Italy.
Lazzeroni D; IRCCS Fondazione Don Carlo Gnocchi, 43100 Parma, Italy.
Sala S; Department of Cardiac Electrophysiology and Arrhythmology, IRCCS San Raffaele Scientific Institute, 20132 Milan, Italy.
Pompilio G; Unit of Vascular Biology and Regenerative Medicine, Centro Cardiologico Monzino IRCCS, 20139 Milan, Italy.; Department of Biomedical, Surgical and Dental Sciences, Università degli Studi di Milano, 20122 Milan, Italy.
Cooper LT; Department of Cardiovascular Medicine, Mayo Clinic, Jacksonville, FL 32224, USA.; Pokaż więcej
Źródło:: Biomolecules [Biomolecules] 2023 Apr 04; Vol. 13 (4). Date of Electronic Publication: 2023 Apr 04.
Typ publikacji:: Journal Article; Review
MeSH Terms:: Myocarditis*/genetics
Cardiomyopathies*/genetics
Cardiomyopathies*/pathology
Heart Failure*/complications
Humans ; Arrhythmias, Cardiac/genetics ; Inflammation/genetics ; Inflammation/complications

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 20.

Tytuł:: Insights into SGLT2 inhibitor treatment of diabetic cardiomyopathy: focus on the mechanisms.
Autorzy:: Huang K; Department of Cardiology, The Affiliated Hospital of Southwest Medical University, Key Laboratory of Medical Electrophysiology, Ministry of Education and Medical Electrophysiological Key Laboratory of Sichuan Province, Institute of Cardiovascular Research, Southwest Medical University, Luzhou, Sichuan, China.
Luo X; Department of Cardiology, The Affiliated Hospital of Southwest Medical University, Key Laboratory of Medical Electrophysiology, Ministry of Education and Medical Electrophysiological Key Laboratory of Sichuan Province, Institute of Cardiovascular Research, Southwest Medical University, Luzhou, Sichuan, China.
Liao B; Department of Cardiovascular Surgery, Metabolic Vascular Diseases Key Laboratory of Sichuan Province, The Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan, China.
Li G; Department of Cardiology, The Affiliated Hospital of Southwest Medical University, Key Laboratory of Medical Electrophysiology, Ministry of Education and Medical Electrophysiological Key Laboratory of Sichuan Province, Institute of Cardiovascular Research, Southwest Medical University, Luzhou, Sichuan, China. .
Feng J; Department of Cardiology, The Affiliated Hospital of Southwest Medical University, Key Laboratory of Medical Electrophysiology, Ministry of Education and Medical Electrophysiological Key Laboratory of Sichuan Province, Institute of Cardiovascular Research, Southwest Medical University, Luzhou, Sichuan, China. .; Pokaż więcej
Źródło:: Cardiovascular diabetology [Cardiovasc Diabetol] 2023 Apr 13; Vol. 22 (1), pp. 86. Date of Electronic Publication: 2023 Apr 13.
Typ publikacji:: Journal Article; Review; Research Support, Non-U.S. Gov't
MeSH Terms:: Sodium-Glucose Transporter 2 Inhibitors*/adverse effects
Diabetic Cardiomyopathies*/drug therapy
Diabetic Cardiomyopathies*/etiology
Diabetic Cardiomyopathies*/metabolism
Heart Failure*
Diabetes Mellitus, Type 2*/complications
Diabetes Mellitus, Type 2*/diagnosis
Diabetes Mellitus, Type 2*/drug therapy
Humans

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Informacja

Wyszukujesz frazę ""CARDIOMYOPATHIES"" wg kryterium: Temat

Źródło danych

Ogranicz do:

Ogranicz do bazy

Typ dokumentu

Temat

Wydawca

Publikacja

Język

Rok publikacji